{"count": 1, "results": [{"_id": "19496972", "pmid": 19496972, "title": "Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit.", "journal": "Pediatr Diabetes", "authors": ["Casteels K", "Fieuws S", "van Helvoirt M", "Verpoorten C", "Goemans N", "Coudyzer W", "Loeckx D", "de Zegher F"], "date": "2010-02-01T00:00:00Z", "doi": "10.1111/j.1399-5448.2009.00512.x", "meta_date_publication": "2010 Feb", "meta_volume": "11", "meta_issue": "1", "meta_pages": "61-9", "score": 50045.227, "text_hl": "Results were similar across diagnostic subgroups. In conclusion, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment for 6 months was associated with a rise in @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity and with a reduction of @DISEASE_Intestinal_Pseudo_Obstruction @DISEASE_MESH:D007418 @@@visceral adiposity@@@ in children and adolescents with a primary @DISEASE_Muscular_Diseases @DISEASE_MESH:D009135 @@@muscle disorder@@@ or with a @<m>DISEASE_Neural_Tube_Defects</m> @DISEASE_MESH:D009436 @@@neural tube defect@@@. ", "citations": {"NLM": "Casteels K, Fieuws S, van Helvoirt M, Verpoorten C, Goemans N, Coudyzer W, Loeckx D, de Zegher F. Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. Pediatr Diabetes. 2010 Feb;11(1):61-9. PMID: 19496972", "BibTeX": "@article{19496972, title={Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit.}, author={Casteels K and Fieuws S and van Helvoirt M and Verpoorten C and Goemans N and Coudyzer W and Loeckx D and de Zegher F}, journal={Pediatr Diabetes}, volume={11}, number={1}, pages={61-9}}"}}]}